Precipitation of fibrin monomers and fibrin degradation products by ristocetin.

Ristocetin precipitation test: a new simple test for detection of fibrin monomer and fibrin degradation products.

fibrinogen degradation products in pleural exudate.

Urinary fibrin degradation products in the newborn.

Fibrin-fibrinogen degradation products in cerebrospinal fluid.

Calcium-binding properties of human fibrin(ogen) and degradation products.

Quantification of fibrin degradation products in glioma and meningioma patients.

Fibrinogen- and fibrin-degradation products during fibrinolytic therapy.

Distinction between fibrinogen and fibrin degradation products in plasma.

Fibrin and fibrinogen degradation products in chronic subdural hematoma.

A method for characterising serum fibrinogen and fibrin degradation products.

fibrinogen degradation products in glomerulonephritis.

Urinary fibrin-fibrinogen degradation products in nephrotic syndrome.

Plasma cross linked fibrin degradation products in pulmonary embolism.

Urinary fibrin and fibrinogen degradation products and the origin of hematuria.

Re-visiting D-dimers and fibrin degradation products for the diagnosis of acute aortic dissection.

Diagnostic implication of fibrin degradation products and D-dimer in aortic dissection.

Fibrinogen-fibrin degradation products in menstrual blood from women with normal and excessive menstrual losses.

Fibrinogen, fibrin degradation products and fibrinolysis in bilharzial (schistosomal) hepatic fibrosis.

Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products.

Raised urinary fibrin-degradation products, complement, and IgG during an influenza-like illness.

Modification of high molecular weight plasmic degradation products of human crosslinked fibrin.

Radioimmunoassay of fibrinogen-fibrin degradation products: assay for fragment E-related neoantigen-methodological aspects.

Factors relevant to stimulatory activity of fibrin degradation products in vivo.

Origin of urinary fibrin-fibrinogen degradation products in renal glomerular disease.

Suggest Documents

Ristocetin precipitation test: a new simple test for detection of fibrin monomer and fibrin degradation products.

fibrinogen degradation products in pleural exudate.

Urinary fibrin degradation products in the newborn.

Fibrin-fibrinogen degradation products in cerebrospinal fluid.

Calcium-binding properties of human fibrin(ogen) and degradation products.

Quantification of fibrin degradation products in glioma and meningioma patients.

Fibrinogen- and fibrin-degradation products during fibrinolytic therapy.

Distinction between fibrinogen and fibrin degradation products in plasma.

Fibrin and fibrinogen degradation products in chronic subdural hematoma.

A method for characterising serum fibrinogen and fibrin degradation products.

fibrinogen degradation products in glomerulonephritis.

Urinary fibrin-fibrinogen degradation products in nephrotic syndrome.

Plasma cross linked fibrin degradation products in pulmonary embolism.

Urinary fibrin and fibrinogen degradation products and the origin of hematuria.

Re-visiting D-dimers and fibrin degradation products for the diagnosis of acute aortic dissection.

Diagnostic implication of fibrin degradation products and D-dimer in aortic dissection.

Fibrinogen-fibrin degradation products in menstrual blood from women with normal and excessive menstrual losses.

Fibrinogen, fibrin degradation products and fibrinolysis in bilharzial (schistosomal) hepatic fibrosis.

Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products.

Raised urinary fibrin-degradation products, complement, and IgG during an influenza-like illness.

Modification of high molecular weight plasmic degradation products of human crosslinked fibrin.

Radioimmunoassay of fibrinogen-fibrin degradation products: assay for fragment E-related neoantigen-methodological aspects.

Factors relevant to stimulatory activity of fibrin degradation products in vivo.

Origin of urinary fibrin-fibrinogen degradation products in renal glomerular disease.

Precipitation of fibrin monomers and fibrin degradation products by ristocetin.

Recommend Documents

Follow Us